Upstream Bio, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Upstream Bio, Inc. (UPB) is 23.14

According to Upstream Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 23.14. This represents a change of -23.02% compared to the average of 30.06 of the last 4 quarters.

Upstream Bio, Inc. (UPB) Historical Current Ratio (quarterly & annually)

How has UPB Current Ratio performed in the past?

The mean historical Current Ratio of Upstream Bio, Inc. over the last ten years is 23.13. The current 23.14 Current Ratio has changed 9.91% with respect to the historical average. Over the past ten years (40 quarters), UPB's Current Ratio was at its highest in in the March 2025 quarter at 47.43. The Current Ratio was at its lowest in in the September 2023 quarter at 0.

Upstream Bio, Inc. (UPB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Upstream Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Upstream Bio, Inc. (UPB) Average Current Ratio

How has UPB Current Ratio performed in the past?

The current Current Ratio of Upstream Bio, Inc. (UPB) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Upstream Bio, Inc. (UPB) Current Ratio vs. Peers

How is UPB’s Current Ratio compared to its peers?

Upstream Bio, Inc.’s Current Ratio is greater than Zenas BioPharma, Inc. (11.94), greater than Intellia Therapeutics, Inc. (6.10), greater than Wave Life Sciences Ltd. (11.26), greater than Relay Therapeutics, Inc. (22.13), greater than Pharvaris N.V. (11.24), greater than Syndax Pharmaceuticals, Inc. (5.47), greater than Novavax, Inc. (2.48), greater than Amylyx Pharmaceuticals, Inc. (17.85), less than Terns Pharmaceuticals, Inc. (62.41), greater than Spyre Therapeutics, Inc. (8.97),

Build a custom stock screener for Upstream Bio, Inc. (UPB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Upstream Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Upstream Bio, Inc. (UPB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Upstream Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.